The conference focuses on the challenges the pharmaceutical sector is experiencing in Egypt and the potential that can be unlocked for a stronger performance.
Chairman of Al-Ahram Foundation Abdel-Mohsen Salama that the conference’s sessions are discussing the role the state is playing in developing the pharmaceutical industry, a digital transformation roadmap for the sector, and sustainable healthcare.
World Health Organisation (WHO) Representative in Egypt Naeema Al-Gasseer stressed that the presidential initiatives launched in the country’s healthcare sector represent a unique model in terms of moving towards inclusive healthcare coverage, citing the One Million Health initiative and the campaign to eradicate hepatitis C.
Al-Gasseer also praised the Decent Life presidential initiative as well as the Digital Egypt initiative, which should contribute to improving the quality of healthcare services.
The Egyptian Presidential Health Advisor Awad Tag El-Din noted that the local pharmaceutical sector has a great opportunity to grow, especially with the keenness of the political leadership to remove any obstacles the sector may experience.
He also asserted the important role the Unified Purchasing Authority is playing in supporting the local pharmaceutical industry, transferring the industry’s technologies to the local market and encouraging investment in this vital sector.
CEO of GSK Mohamed El-Dababi said that local pharmaceutical manufacturing in the Middle East and North Africa region represents 32 percent of the global industry, adding that Egypt is one of the pioneering countries in pharmaceutical industry localisation.
On the other hand, El-Dababi pointed out that the sector’s imports exceed its exports by tenfold, which requires focusing on lowering reliance on imports by increasing investments in the sector and local manufacturing.